BNP Paribas Financial Markets
ABVX

BNP Paribas Financial Markets’s Abivax ABVX Stock Holding History

BNP Paribas Financial Markets’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.49M Buy
40,362
+37,345
+1,238% +$4.42M ﹤0.01% 2109
2025
Q4 		$407K Buy
3,017
+1,217
+68% +$133K ﹤0.01% 3682
2025
Q3 		$153K Sell
1,800
-8,870
-83% -$544K ﹤0.01% 4124
2025
Q2 		$81.6K Sell
10,670
-776
-7% -$5.06K ﹤0.01% 4080
2025
Q1 		$71.5K Sell
11,446
-7,798
-41% -$52.8K ﹤0.01% 4162
2024
Q4 		$141K Buy
19,244
+6,200
+48% +$57.1K ﹤0.01% 4040
2024
Q3 		$150K Buy
13,044
+5,900
+83% +$70.7K ﹤0.01% 3357
2024
Q2 		$94.4K Buy
7,144
+1,500
+27% +$21.4K ﹤0.01% 3305
2024
Q1 		$80.7K Buy
+5,644
New +$72.8K ﹤0.01% 3489

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

BNP Paribas Financial Markets's ABVX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Abivax (ABVX) stake by 1,238% in Q1 2026, buying an estimated $4.42M and bringing the position to 40,362 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

BNP Paribas Financial Markets first reported a position in ABVX in Q1 2024 and has held it in 9 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • BNP Paribas Financial Markets held 40,362 shares of Abivax worth $4.49M as of Q1 2026.
  • BNP Paribas Financial Markets bought 37,345 Abivax shares in Q1 2026, an estimated $4.42M.
  • Abivax made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #2109 holding.
  • BNP Paribas Financial Markets first reported a position in Abivax in Q1 2024 and has held it in 9 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.